184 related articles for article (PubMed ID: 11368557)
61. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
Wihlén B; Ahmed S; Inzunza J; Matthews J
Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
[TBL] [Abstract][Full Text] [Related]
62. Inhibition of carcinogen-activating enzymes by 16alpha-fluoro-5-androsten-17-one.
Ciolino HP; MacDonald CJ; Yeh GC
Cancer Res; 2002 Jul; 62(13):3685-90. PubMed ID: 12097275
[TBL] [Abstract][Full Text] [Related]
63. Aryl hydrocarbon (Ah) nonresponsiveness in estrogen receptor-negative MDA-MB-231 cells is associated with expression of a variant arnt protein.
Wilson CL; Thomsen J; Hoivik DJ; Wormke MT; Stanker L; Holtzapple C; Safe SH
Arch Biochem Biophys; 1997 Oct; 346(1):65-73. PubMed ID: 9328285
[TBL] [Abstract][Full Text] [Related]
64. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.
Hayes CL; Spink DC; Spink BC; Cao JQ; Walker NJ; Sutter TR
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9776-81. PubMed ID: 8790407
[TBL] [Abstract][Full Text] [Related]
65. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.
Hanna IH; Dawling S; Roodi N; Guengerich FP; Parl FF
Cancer Res; 2000 Jul; 60(13):3440-4. PubMed ID: 10910054
[TBL] [Abstract][Full Text] [Related]
66. Preferential induction of CYP1A1 over CYP1B1 in human breast cancer MCF-7 cells after exposure to berberine.
Wen CJ; Wu LX; Fu LJ; Shen DY; Zhang X; Zhang YW; Yu J; Zhou HH
Asian Pac J Cancer Prev; 2014; 15(1):495-9. PubMed ID: 24528081
[TBL] [Abstract][Full Text] [Related]
67. Enhancement of 2- and 16 alpha-estradiol hydroxylation in MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-P-dioxin.
Gierthy JF; Lincoln DW; Kampcik SJ; Dickerman HW; Bradlow HL; Niwa T; Swaneck GE
Biochem Biophys Res Commun; 1988 Dec; 157(2):515-20. PubMed ID: 3202862
[TBL] [Abstract][Full Text] [Related]
68. Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.
Chua MS; Kashiyama E; Bradshaw TD; Stinson SF; Brantley E; Sausville EA; Stevens MF
Cancer Res; 2000 Sep; 60(18):5196-203. PubMed ID: 11016648
[TBL] [Abstract][Full Text] [Related]
69. Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1.
Katiyar SK; Matsui MS; Mukhtar H
J Invest Dermatol; 2000 Feb; 114(2):328-33. PubMed ID: 10651994
[TBL] [Abstract][Full Text] [Related]
70. Differential Effects of Glycyrrhiza Species on Genotoxic Estrogen Metabolism: Licochalcone A Downregulates P450 1B1, whereas Isoliquiritigenin Stimulates It.
Dunlap TL; Wang S; Simmler C; Chen SN; Pauli GF; Dietz BM; Bolton JL
Chem Res Toxicol; 2015 Aug; 28(8):1584-94. PubMed ID: 26134484
[TBL] [Abstract][Full Text] [Related]
71. Evidence for an aryl hydrocarbon receptor-mediated cytochrome p450 autoregulatory pathway.
Chiaro CR; Patel RD; Marcus CB; Perdew GH
Mol Pharmacol; 2007 Nov; 72(5):1369-79. PubMed ID: 17720764
[TBL] [Abstract][Full Text] [Related]
72. Identification of cytochrome P450 isoforms involved in 1-hydroxylation of pyrene.
Kim YD; Todoroki H; Oyama T; Isse T; Matsumoto A; Yamaguchi T; Kim H; Uchiyama I; Kawamoto T
Environ Res; 2004 Mar; 94(3):262-6. PubMed ID: 15016593
[TBL] [Abstract][Full Text] [Related]
73. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP
Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012
[TBL] [Abstract][Full Text] [Related]
74. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation.
Jellinck PH; Forkert PG; Riddick DS; Okey AB; Michnovicz JJ; Bradlow HL
Biochem Pharmacol; 1993 Mar; 45(5):1129-36. PubMed ID: 8384853
[TBL] [Abstract][Full Text] [Related]
75. Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene.
Chun YJ; Oh YK; Kim BJ; Kim D; Kim SS; Choi HK; Kim MY
Toxicol Lett; 2009 Aug; 189(1):84-9. PubMed ID: 19463925
[TBL] [Abstract][Full Text] [Related]
76. Modulating potential of L-sulforaphane in the expression of cytochrome p450 to identify potential targets for breast cancer chemoprevention and therapy using breast cell lines.
Licznerska B; Szaefer H; Matuszak I; Murias M; Baer-Dubowska W
Phytother Res; 2015 Jan; 29(1):93-9. PubMed ID: 25234182
[TBL] [Abstract][Full Text] [Related]
77. Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cells.
Spink BC; Bennett JA; Lostritto N; Cole JR; Spink DC
Mol Carcinog; 2013 Jul; 52(7):544-54. PubMed ID: 22388733
[TBL] [Abstract][Full Text] [Related]
78. A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis.
Chun YJ; Kim S; Kim D; Lee SK; Guengerich FP
Cancer Res; 2001 Nov; 61(22):8164-70. PubMed ID: 11719446
[TBL] [Abstract][Full Text] [Related]
79. Phytoestrogens modulate the expression of 17alpha-estradiol metabolizing enzymes in cultured MCF-7 cells.
Wagner J; Jiang L; Lehmann L
Adv Exp Med Biol; 2008; 617():625-32. PubMed ID: 18497090
[TBL] [Abstract][Full Text] [Related]
80. Transcriptional regulation of the human CYP1B1 gene. Evidence for involvement of an aryl hydrocarbon receptor response element in constitutive expression.
Shehin SE; Stephenson RO; Greenlee WF
J Biol Chem; 2000 Mar; 275(10):6770-6. PubMed ID: 10702233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
